Together, these findings provide a mechanistic rationale for targeting the CIP2A-TOPBP1 axis, as well as downstream repair pathways involving SLX4 and Polθ, particularly in tumours that exhibit elevated replicative stress. This evidence concerns the gene SLX4 and neoplasm.